Actinium Pharmaceuticals Inc. logo

Actinium Pharmaceuticals Inc.

ATNM | AMEX
Chart Builder DCF Calculator
$1.20
$0 (0.00%)
Sep 22, 2026, 10:39 AM ET · Market open

Market Data

Market Cap
$37.65M
Enterprise Value
$2.52M
Beta
0.02
Average Volume
128.26K
Shares Outstanding (Diluted)
31.41M
Shares Change YoY
0.68%
Institutional Ownership
16.97%
Exchange
AMEX
ISIN
US00507W2061

Price Performance

Price Change 1M
9.1%
Price Change 3M
17.6%
Price Change 6M
11.1%
Price Change YTD
-12.4%
Price Change 1Y
-26.4%
Price Change 3Y
-81.0%
Price Change 5Y
-87.6%
1M CAGR (ann.)
50.5%
1Y CAGR (ann.)
-27.3%
5Y CAGR (ann.)
-27.3%
All-Time CAGR
-23.2%

Valuation

PE Ratio
3.33
Forward PE
N/A
PEG Ratio
0.01
Forward PEG
-0.01
PS Ratio
1.07
Forward PS
1.90
PB Ratio
1.24
P/FCF Ratio
-1.62
P/Adj. FCF Ratio
-1.60
P/OCF Ratio
-1.67
EV/Sales
0.07
EV/EBIT
-0.15
EV/EBITDA
0.22
EV/FCF
-0.11
Earnings Yield
30.0%
FCF Yield
-61.8%
Adj. FCF Yield
-62.4%

Financial Health

Net Cash
$35.13M
Total Debt
$1.34M
Cash & Short-Term Investments
$36.47M
Total Assets
$40.16M
Current Ratio
4.08
Quick Ratio
4.08
Debt / Equity Ratio
0.04
Debt / EBITDA
0.12
Debt / FCF
-0.06
OCF / Debt
-16.90
Interest Coverage
0.00
Altman Z-Score
-10.85
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
101.1%
Operating Profit Margin
27.2%
EBITDA Margin
34.7%
Net Profit Margin
32.2%
FCF Margin
-66.3%
Adj. FCF Margin
-67.0%
SBC / Revenue
0.7%
SBC Impact (per share)
-1.1%

Returns

Return on Assets
28.2%
Return on Equity
83.4%
Return on Invested Capital
30.2%
Return on Capital Employed
30.9%
Return on Tangible Assets
28.2%

Historical Growth (CAGR)

Revenue CAGR 3Y
820.4%
Revenue CAGR 5Y
108.6%
Revenue CAGR 10Y
51.4%
EPS CAGR 3Y
114.2%
EPS CAGR 5Y
33.2%
EPS CAGR 10Y
33.3%
FCF CAGR 3Y
18.3%
FCF CAGR 5Y
-23.9%
FCF CAGR 10Y
-5.0%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
11
EPS Growth Next 3Y
-57.4%
Revenue Growth Next 3Y
62.8%
Earnings Date
Nov 12, 2026
EPS Estimate (next Q)
-$0.25
EPS Growth Est (next Q)
56.3%
Revenue Est (next Q)
$1.25M
Revenue Growth Est (next Q)
1284.4%

Fair Value Estimates

Graham Number
$2.80
Graham Upside
133.3%
Lynch Fair Value
$9
Lynch Upside
650.0%
Price Target
$11.07
Price Target Upside
822.5%

Cash Flow

Operating Cash Flow
$-22.66M
Free Cash Flow
$-23.25M
Adj. Free Cash Flow
$-23.5M
FCF Per Share
-$0.74
OCF Per Share
-$0.72
OCF/S Ratio
-64.6%

Income Statement

Revenue
$35.09M
Gross Profit
$485K
Operating Income
$9.56M
EBITDA
$11.6M
Net Income
$11.31M
EPS (Diluted)
$0.36
Revenue / Employee
$1.3M
Profit / Employee
$418.81K
Employees
27

© 2026 bestshares.com. All rights reserved.